Edit

Dezima Pharma

http://investors.amgen.com/phoenix.zhtml?c=61656&p%20=irol-newsArticle&ID=2088272

Last activity: 07.02.2024

Categories: BusinessFinTechHumanInformationResearchWebsite

The Investor Relations website contains information about Amgen Inc.'s business for stockholders, potential investors, and financial analysts.

Website visits

23.3K /mo.

Mentions

Location: United States, California, Thousand Oaks

Instagram

Youtube

Investors 2

Date	Name	Website
03.08.2021	BioGenerat...	biogenerat...
-	TPG	tpg.com

Mentions in press and media 26

Date	Title	Description	Source
07.02.2024	The GLP-1 panic is alive and well	Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne...	statnews.c...
09.11.2022	Arrowhead Gets $250M in Royalty Deal for Cardio Drug Heading...	Arrowhead Pharmaceuticals is turning its financial tie to a promising but still experimental heart d...	medcitynew...
22.09.2021	Amgen : Investor Presentation September 2021	INVESTOR PRESENTATION SEPTEMBER 2021 SAFE HARBOR STATEMENT This presentation contains forward-lookin...	marketscre...
26.08.2021	Amgen : Investor Presentation August 2021	INVESTOR PRESENTATION AUGUST 2021 SAFE HARBOR STATEMENT This presentation contains forward-looking s...	marketscre...
01.06.2021	Eying eczema, Amgen pays $400M to co-develop Phase 3-ready K...	Amgen is vying to bolster its immunology drug portfolio and it is paying $400 million to do it. The ...	medcitynew...
18.05.2021	AMGEN INC. Amgen : 2021 Annual Meeting of Stockholders Pres...	2021 Annual Meeting of Stockholders May 18, 2021 RECONCILIATIONS Amgen Inc. GAAP to Non-GAAP Reconci...	marketscre...
31.03.2021	UPDATED: Biotech pioneer and startup investor John Mar...	With blockbuster immunology meds Enbrel and Otezla already in the fold, Amgen has mostly stood pat o...	endpts.com...
31.03.2021	UPDATED: Biotech pioneer and startup investor John Mar...	BridgeBio $BBIO is on a roll. At the end of February, they won an approval for their first drug, a t...	endpts.com...
30.03.2021	After pilot project, Takeda inks $500M pact to tap into ...	As new technologies open up new avenues toward targets widely considered undruggable by sm...	endpts.com...
30.03.2021	Novartis dives even deeper into radioligands, notchi...	Novartis captured attention last week for its Phase III prostate cancer win with a radiolig...	endpts.com...
16.02.2021	Weeks after dropping big response data, Amgen lines up ...	Amgen is looking to go where no other drugmaker has gone before with the KRAS inhibitor soto...	endpts.com...
23.12.2020	Amgen hands off rights to leprosy, tuberculosis med pi...	Amgen scored a big pickup with its acquisition of immunology blockbuster Otezla from Bris...	endpts.com...
02.07.2018	AbbVie spent billions on a buzzy Silicon Valley cancer drug ...	Flickr/Ed Uthman Advertisement The cancer-stem-cell company Stemcentrx was one of the biggest ventur...	businessin...
12.12.2017	Ex-Dezima CEO co-founds NASH startup, flying into Phase...	Rob de Ree A new Dutch biotech, co-founded and led by the former CEO of Dezima, is launching wi...	endpts.com...
30.10.2017	Bristol-Myers, J&J sink cash into a new $95M Europe...	A venture capital firm in the Netherlands — backed by some big names in Big Pharma — has raised...	endpts.com...
02.05.2017	Globalized genomics: WuXi NextCODE raises $75M Series B	In an email forwarded by a company representative, WuXi NextCODE CEO Hannes Smarason said the produc...	medcitynew...
25.04.2017	With late-stage data in on the CGRP migraine drug erenuma...	Five months after Amgen and Novartis outlined their second batch of positive Phase III data...	endpts.com...
16.11.2016	Bristol-Myers partners with Enterome on a gut-level ap...	Carl Decicco, Bristol-Myers Squibb Bristol-Myers Squibb has turned to Paris-based microbio...	endpts.com...
26.10.2016	Genomics Medicine Ireland raises $40 million for large-scale...	Irish Taoiseach (Prime Minister) Enda Kenny formally announced the news, highlighting the local econ...	medcitynew...
27.09.2016	Amgen hit with a setback as Kyprolis fails a key frontli...	Sean Harper, Executive Vice President, Research and Development Amgen reported early T...	endpts.com...
27.10.2015	Herpes virus that attacks cancer is first of new viral thera...	Viruses are usually thought of as agents of disease. But for the first time, scientists are poised t...	statnews.c...
17.12.2008	KAI Pharmaceuticals Initiates Phase 2b Clinical Study of KAI...	Learn More-External Link	lumiravent...
10.12.2008	KAI-1678, First-in-Class Compound, Enters Phase 2a Clinical ...	Learn More-External Link	lumiravent...
-	Eying eczema, Amgen pays $400M to co-develop Phase 3-ready K...	Amgen is vying to bolster its immunology drug portfolio and it is paying $400 million to do it. The ...	medcitynew...
-	Genomics Medicine Ireland raises $40 million for large-scale...	GMI Co-Founders, Dan Crowley, Paul Thurk, Sean Ennis, Maurice Treacy and Irish PM, Enda Kenny The 4....	medcitynew...
-	Globalized genomics: WuXi NextCODE raises $75M Series B	WuXi NextCODE, a so-called contract genomics organization (CGO), has raised $75 million in a new Ser...	medcitynew...

Dezima Pharma

Investors 2

Mentions in press and media 26

Reviews 0